Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Pro Medicus (ASX:PME) — Why ASX Medical AI Is Back in the Spotlight

• Pro Medicus (ASX:PME) is in the market spotlight because of a fresh market-moving catalyst that has changed the investor conversation.

Sonal Goyal | 29 June 2026

EchoIQ (ASX:EIQ) Readies $100m Cash Call After Pro Medicus Deal — Is This the Next ASX Medical AI Story?

• EchoIQ (ASX:EIQ) is in the market spotlight because of a fresh market-moving catalyst that has changed the investor conversation.

Sonal Goyal | 29 June 2026

Regal’s Small-Cap Recruit Names Artrya (ASX:AYA) as a Potential ‘10-Bagger’ — Can This ASX Medical Software Stock Deliver?

• Artrya (ASX:AYA) is in the market spotlight because of a fresh market-moving catalyst that has changed the investor conversation.

Sonal Goyal | 29 June 2026

Singular Health (ASX:SHG) Share Price Rises 2.9% as Investors Turn to Health-Tech Stocks

Singular Health (ASX:SHG) attracted investor attention after its shares climbed approximately2.9%during the latest trading session. While no verified company-specific announcement appeared to drive the move, the stock benefited from improving sentiment across the healthcare and biotechnology sector.

Aditi Sarkar | 29 June 2026

Beamtree Holdings (ASX:BMT) Share Price Climbs 10.7%: Why Investors Are Watching the Health-Tech Stock

Beamtree Holdings Ltd attracted strong investor attention after its shares climbed around 10.7%, making it one of the standout performers on the ASX. Although the stock recorded a significant gain, there was no confirmed company-specific announcement accompanying the move, indicating that broader market sentiment …

Aditi Sarkar | 29 June 2026

Pro Medicus Ltd (ASX:PME): Can Its Strategy and Healthcare Imaging Leadership Support Long-Term Growth?

Pro Medicus Ltd (ASX: PME) has built its business around this opportunity. The company develops healthcare imaging software and radiology information system (RIS) solutions used by hospitals, imaging centres and healthcare groups across Australia, North America and Europe. Its focus on enterprise imaging and …

Aditi Sarkar | 27 June 2026

CSL (ASX:CSL): CSL’s Slide Puts Australia’s Biotech Champion Under the Market Microscope

• CSL (ASX: CSL) appears as the large-cap Australian companies screen with a market capitalisation of about 56.34 B AUD in the snapshot used for this article.

Aditi Sarkar | 26 June 2026

Argent Biopharma (ASX: RGT): Could This Biopharma Stock Become a High-Risk Watchlist Name?

• Argent Biopharma (ASX:RGT) is a small-cap ASX stock appearing on the supplied Australian small-cap stock list.

Aditi Sarkar | 26 June 2026

Tali Digital (ASX: TD1): Is This Digital Health Stock Ready for a Fresh Market Story?

• Tali Digital (ASX:TD1) is a small-cap ASX stock appearing on the supplied Australian small-cap stock list.

Aditi Sarkar | 26 June 2026

Chimeric Therapeutics (ASX: CHM): Could Cancer-Therapy Stock CHM Be Back on Biotech Watchlists?

• Chimeric Therapeutics (ASX:CHM) is a small-cap ASX stock appearing on the supplied Australian small-cap stock list.

Aditi Sarkar | 26 June 2026
Support

Hi! How can we help you today?

Loading…